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SUMMARY
We show that sweetening of food products by natural fermentation can be achieved by a combined metabolic engineering and transcriptome analysis approach. A Lactococcus lactis ssp. cremoris strain was constructed in which glucose metabolism was completely disrupted by deletion of the genes coding for glucokinase (glk), EII man/glc (ptnABCD), and the newly discovered glucose-PTS EII cel (ptcBAC). After introducing the lactose metabolic genes, the deletion strain could solely ferment the galactose moiety of lactose, while the glucose moiety accumulated extracellularly. Additionally, less lactose remained in the medium after fermentation. The resulting strain can be used for in situ production of glucose, circumventing the need to add sweeteners as additional ingredients to dairy products. Moreover, the enhanced removal of lactose achieved by this strain could be very useful in the manufacture of products for lactose intolerant individuals.
INTRODUCTION
Nutraceuticals comprise a wide range of foods or food components, including fermenting bacteria, with a claimed medical or health benefit. Lactococcus lactis is a lactic acid bacterium used in the dairy industry for the production of fermented milk products and, thus, is a good target for the production of nutraceuticals. Additionally, L. lactis is a suitable model organism for metabolic pathway engineering (73), since it has a relatively simple carbon metabolism and many molecular cloning tools are available (84, 95, 96) . The metabolism of L. lactis has already been successfully engineered, e.g. for the production of the sweet amino acid L-alanine (61), the production of the buttery flavor diacetyl (64), the production of mannitol (51, 219) , and for the simultaneous overproduction of the vitamins folate and riboflavin (183).
The aim of the present study was to disrupt glucose uptake and metabolism in L. lactis in such a way that, when growing on lactose it excretes glucose, which can be used as a natural sweetener in dairy products. A second goal was to reduce lactose contents in the final product. Like in many other bacteria, the phosphoenolpyruvate:sugar phosphotransferase system (PEP:PTS), mediating uptake and phosphorylation of carbohydrates (42, 148, 161) , is the main sugar transport system in L. lactis. Uptake of glucose in L. lactis can take place either via these PEP:PTS systems or via one or more non-PTS transporter(s), after which the sugar is phosphorylated to glucose-6-phosphate by glucokinase. Subsequently, glucose-6-phosphate enters glycolysis (Fig. 1) . PEP:PTS systems for six different (types of) sugars, i.e. fructose, mannose, sucrose, mannitol, β-glucosides and cellobiose, have been annotated in the nucleotide sequence of the genome of L. lactis ssp. lactis IL1403 (15). Homologues of these PTS genes are present in the genome sequence of L. lactis ssp. cremoris MG1363 (215). The mannose/glucose-PTS is considered to be the main uptake system for glucose (195) . The milk-sugar lactose is imported by a dedicated PEP:PTS lac . The lactose-phosphate formed during transport is hydrolyzed intracellularly to galactose-6-phosphate, which is metabolized further through the tagatose-6-phosphate pathway, and to glucose, which enters glycolysis after phosphorylation by glucokinase. The genes for lactose usage are located on the lactococcal plasmid pMG820 (106) (Fig. 1) . Directed engineering of L. lactis results in stable and clear genotypes, in contrast to genotypes resulting from classical mutagenesis techniques, by which various genetic changes may go undetected (6, 128). The directed engineering approach proposed here, involving deletion of a known and a newly discovered PTS-system specific for glucose and the gene encoding glucokinase, as well as the introduction of the lactose metabolic genes, resulted in a strain producing glucose (Fig. 1 ). Lactose is taken up by the lactose-PTS specified by plasmid pMG820 (Lac + ). The galactose moiety of lactose is used for metabolism via the tagatose-6-phosphate pathway, also supplied in pMG820. The glucose moiety is phosphorylated by glucokinase before entering glycolysis. Glucose can be imported via either the PTS man/glc (ptnABCD) or the newly discovered PTS cel (ptcBAC, encircled), consisting of a cytosolic EIIAB-part and an integral membrane EIICD-part or a cytosolic EIIAB-part and an integral membrane EIIC-part, respectively. Glucose is excreted as observed in L. lactis NZ9000Glc -Lac + . Question-mark: unidentified glucose transporter(s). Dashed crosses: glk, ptnABCD, and ptcBA deletions made in this study.
The fate of carbon in each sugar moiety during lactose fermentation in the engineered strains was investigated using 13 C-labelled substrates and in vivo Nuclear Magnetic Resonance (NMR) (124). The production of glucose from lactose could be demonstrated in non-growing cells as well as during cell growth in defined medium and during growth in skim milk.
EXPERIMENTAL PROCEDURES

Microbial strains and growth conditions
Strains and plasmids used in this study are listed in Table 1 . The strains were grown in M17 (Difco, Sparks, MD) with 0.5% galactose (w/v) or 2% lactose (w/v) at 30ºC or 37°C, in chemically defined medium (CDM (144)), with 1% glucose (w/v) or 2% lactose (w/v) or in 10% reconstituted skim milk (Oxoid Ltd., Basingstoke, England). The optical density of milk-grown culture was measured using the milk clearing method of Kanasaki (69) , in which 100 μl of culture was mixed with 900 μl 0.5 M borate (pH 8.0) containing 10 mM EDTA; after 30 minutes incubation at room temperature the optical density at 600 nm was measured. When necessary, erythromycin and chloramphenicol were used at a final concentration of 5 μg/ml. For growth in a 2 L fermentor (New Brunswick BioFlo, Edison, NJ), the medium was gassed with argon for 10 min prior to inoculation (4% inoculum from a culture grown overnight); the pH was kept at 6.5 by automated addition of 5 N NaOH, and an agitation rate of 70 rpm was used. Growth was monitored by measuring the optical density at 595 or 600 nm.
DNA techniques
General DNA techniques were performed essentially as described (162). Plasmid DNA was isolated by the method of Birnboim and Doly (12). Restriction enzymes, T4 DNA ligase, Expand polymerase and Taq polymerase were obtained from Roche Applied Science (Mannheim, Germany) and used according to the supplier's instructions. PCR was performed in an Eppendorf thermal cycler (Eppendorf, Hamburg, Germany).
Specific cloning procedures
Gene deletions were all performed in L. lactis strain NZ9000 and were constructed with the help of L. lactis strains LL108 and LL302 and pORI280-derivatives using a two-step homologous recombination method described before (96). This method does not leave antibiotic resistance markers in the chromosome, and multiple deletions in one strain can be easily realized. Primers used for cloning are listed in Table 1 . Chromosomal DNA of L. lactis NZ9000 was used as a template in PCR amplifications. An L. lactis NZ9000Δglk strain, in which only the first 360 bp were left of the 969 bp of glk, was engineered using the primers glk5, glk6, glk7, and glk8. L. lactis NZ9000ΔptnABCD, in which ptnAB is disrupted after 578 bp, ptcC is completely deleted and the first 441 bp of ptcD are missing, was made using the primers ptn1, ptn2, ptn3, and ptn4. L. lactis NZ9000ΔptcBA, carrying only the first 36 bp of ptcB and the last 58 bp of ptcA, was made using the primers ptc1, ptc2, ptc3, and ptc4.
Glucokinase enzymatic assays
Cells ( ~10 9 ) were harvested at mid-exponential growth-phase, resuspended in 1 ml 10 mM potassium phosphate (KP i ) buffer (pH 7.2) and disrupted with 0.5 g glass beads (∅ 50-105 μm, Fischer Scientific BV, Den Bosch, the Netherlands), using a Mini-BeadBeater-8 (Biospec Products, Inc., Bartlesville, OK) with two 1 min pulses of homogenization, and a 1 min interval on ice. Cell debris was pelleted and glucokinase activity in the cell-free extract was assayed spectrophotometrically by the glucose-6-phosphate dehydrogenase (Glc6P-DH) (EC1.1.1.49) : NADPHcoupled assay (147). The assay mixture contained 10 mM KP i (pH 7.2), 5 mM MgCl 2 , 1 mM NADP + , 1 mM ATP, 1 U Glc6P-DH, 20 mM glucose and cell-free extract (usually 20 μl) in a total volume of 250 μl. Protein was determined by the method of Bradford (19).
In vivo NMR
Cells were grown in medium containing 2% lactose (w/v), harvested in the midlogarithmic phase of growth, and were resuspended in 50 mM KP i buffer (pH 6.5) to a protein concentration of approximately 15 mg protein / ml. In vivo NMR experiments were performed using the on-line system described earlier (124). Lactose specifically labeled on the galactose moiety ([1-
13
C Gal ]-lactose, 20 mM) or on the glucose moiety ([1-
C Glc ]-lactose, 20 mM) was added to the cell suspension at time-point zero. The time course of lactose consumption, product formation, and changes in the pools of intracellular metabolites were monitored in vivo. When the substrate was exhausted and no changes in the resonances of intracellular metabolites were observed, an NMR-sample extract was prepared as described previously (124, 127). Carbon-13 spectra were acquired at 125.77 MHz on a Bruker DRX500 spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany). All in vivo experiments were run using a quadruple nuclei probe head at 30 o C, as described before (124). Lactate was quantified in the NMR-sample extract by 1 H-NMR in a Bruker AMX300 (Bruker BioSpin GmbH). The concentration of other metabolites (e.g. glucose) was determined in fully relaxed 13 C spectra of the NMR-sample extracts as described (127).
Transcriptome analysis
mRNA-levels of L. lactis strains NZ9000 and NZ9000ΔglkΔptnABCD were compared by transcriptome analysis using L. lactis DNA-microarrays (83). The strains were grown independently 3 times with Cy3 and Cy5-dye-swaps of each repetition. Thus, a total of 6 hybridized slides, all containing duplicate spots of each amplicon, resulted in a maximum of 12 measurements for each gene. The experiments were performed essentially as described (83), with the following modifications. RNA-isolation. Macaloid was prepared by resuspending 2 g Macaloid (Bentone MA, Elementis Specialities Inc, Hightstown, NJ) in 100 ml 10 mM Tris / 1 mM EDTAbuffer (T 10 E 1 ) (pH 8.0), boiling for 5 min, cooling to room temperature, sonicating by burst until the macaloid formed a gel, centrifuging and resuspending in 50 ml T 10 E 1 (pH 8.0). Cells (40 ml; ~2 x 10 9 ) were harvested at the mid-exponential growth phase by centrifugation (13,000 x g, 1 min, 20°C) and the cell pellets were immediately frozen in liquid nitrogen. After thawing on ice, the cells were resuspended in 500 μl T 10 E 1 (pH 8.0) (treated with DEPC; Sigma-Aldrich, St. Louis, MO), and placed in a rubber sealed screw-capped tube. After adding 500 mg glass beads (∅ 50-105 μm), 50 µl 10% SDS, 500 µl phenol / chloroform, and 175 μl Macaloid, the cells were disrupted in a Mini-BeadBeater-8 (Biospec Products, Inc.) using two 1 min pulses (homogenize), with a 1 min interval on ice. After centrifugation (20,000 x g, 10 min, 4°C), 500 μl of supernatant was extracted with 500 μl phenol / chloroform, centrifuged as before, followed by an extraction with only 500 μl chloroform. After centrifugation (20,000 x g, 5 min, 4°C), total RNA was isolated from the water phase using the 'High Pure RNA Isolation Kit' of Roche Applied Science, according to the manufacturer's instructions, except that final elution was performed with 50 μl elution buffer. RNA yield was determined spectrophotometrically at 260 nm. RNA quality was examined using the Agilent 2100 Bioanalyzer (Agilent Technologies, Amstelveen, the Netherlands). cDNA labeling and hybridization. Single-strand reverse transcription and indirect labeling of 20 µg of total RNA with Cy3-dCTP or Cy5-dCTP were performed with the CyScribe Post Labelling Kit of Amersham (Roosendaal, the Netherlands) according to the manufacturer's instructions. Hybridization of the purified labeled cDNA to an aldehyde-coated glass slide (Cel Associates / Telechem International Inc., Sunnyvale, CA) on which 2108 amplicons of L. lactis strain IL1403 had been spotted in duplicate, was performed as described (83) at 42°C. Bioinformatic analysis. Spot quantitations were processed and normalized using automated grid-based Lowess transformation (f = 0.5) software (208). Differentially expressed genes were selected at a p-value lower than 0.00001 and a ratio of 2 and higher by using a variant of the paired t-test on normalized ratio data (101). (69) before centrifugation (2,000 × g, 5 min, 4ºC). Supernatants were filtered over 0.45 μm nylon membranes (Millipore, Bedford, MA) and stored at -20ºC until analysis by high performance liquid chromatography using a refractive index detector (Shodex RI-101, Showa Denko K. K., Japan). Lactose, glucose and galactose in the supernatants of CDM-grown cultures were quantified using an Aminex HPX-87P column (Bio-Rad Laboratories Inc., Hercules, CA) at 80ºC, with H 2 O as the elution fluid and a flow rate of 0.6 ml / min. Lactose, glucose, and galactose in the supernatants of milk-grown cultures were quantified using an HPX-87H anion exchange column (Bio-Rad Laboratories Inc.) at 60ºC, with 5 mM H 2 SO 4 as the elution fluid and a flow rate of 0.5 ml / min.
Sugar determinations by HPLC
Samples of L. lactis
RESULTS
Deletion of glk and ptnABCD is not sufficient to fully block glucose metabolism
As a first step in the process of blocking glucose metabolism, a deletion was made in the glucokinase gene (glk) in L. lactis ssp. cremoris strain NZ9000 (Fig. 1) . NZ9000 showed glucokinase activity (0.14 ± 0.02 U/mg), while no glucosephosphorylating activity was detected in NZ9000Δglk. The latter strain was still able to grow in chemically defined medium (CDM) with 1% (w/v) glucose, although the growth characteristics were different from those of strain NZ9000 (Fig. 2) . L. lactis strains NZ9000 (■), NZ9000Δglk (□), NZ9000ΔglkΔptnABCD (•), NZ9000ΔglkΔptcBA (○) and NZ9000Glc⎯ (▲) were grown in CDM with 1.0% glucose at 30°C in microtiterplates. OD595 was measured at 1 hr intervals. For each strain the μ max is presented in the inset.
NZ9000Δglk showed a lower maximum growth rate and the culture reached a higher final cell density. As NZ9000Δglk is unable to use intracellular glucose, or glucose imported via a non-PTS permease system, growth of this strain on glucose is strictly dependent on uptake via one or more PEP:PTS(s). Removal via double cross-over recombination of the genes encoding the mannose/glucose-PTS (ptnABCD) in L. lactis NZ9000Δglk resulted in a strain (NZ9000ΔglkΔptnABCD) still able to grow on glucose (Fig. 2) . Surprisingly, the growth characteristics of L. lactis NZ9000ΔglkΔptnABCD resembled those of NZ9000Δglk in CDM with 1% (w/v) glucose without pH-control, although the maximum growth rate of the double mutant was slightly higher. These results indicated that, apart from EII man/glc , another efficient glucose-PTS is functional in L. lactis NZ9000.
Transcriptome analysis indicates the additional glucose PTS in L. lactis
To elucidate which PEP:PTS besides EII man/glc is able to transport glucose in L. lactis NZ9000, mRNA-levels in strains NZ9000 and NZ9000ΔglkΔptnABCD grown in CDM with 1% (w/v) glucose were compared using DNA-microarrays. The assumption was that the gene(s) encoding the glucose-PTS operative in NZ9000ΔglkΔptnABCD would be expressed at a higher level in this mutant than in L. lactis NZ9000. In NZ9000ΔglkΔptnABCD, the genes ptcB and ptcA were both overexpressed more than 5 times, while none of the other PTS-genes were significantly overexpressed ( Table 2) . (Fig. 2) , showing that ptcBA is part of a glucose transporter. Removal of glk, ptnABCD, and ptcBA was sufficient to fully block glucose metabolism in L. lactis NZ9000, and this glucose-negative NZ9000-derivative will be named NZ9000Glc⎯ from here onwards. As L. lactis strains NZ9000ΔglkΔptcBA and NZ9000ΔglkΔptnABCD could metabolize glucose (Fig. 2) , both L. lactis EII cel and EII man/glc can use glucose as a substrate.
Furthermore, the ability to use cellobiose as a substrate was heavily impaired in strain NZ9000ΔptcBA (data not shown), showing that EII cel also plays a role in cellobiose uptake in L. lactis.
NZ9000Glc -Lac + produces glucose under several conditions
Lactococcal plasmid pMG820, carrying the genes for lactose-PTS and the tagatose-6-phosphate pathway (106), was introduced in L. lactis strains NZ9000 and NZ9000Glc⎯, providing both strains with the ability to use lactose as a substrate (Lac + ). Growth of the two resulting strains in CDM with 2% (w/v) lactose was analyzed in batch cultures with and without pH control. Sugar (lactose, glucose, and galactose) concentrations in the medium were determined at several points during growth using High Performance Liquid Chromatography (HPLC). L. lactis NZ9000Glc⎯Lac + had a lower maximum growth rate and the culture-pH dropped more slowly than that of L. lactis NZ9000Lac + when the strains were grown as standing cultures without pH-control (Fig. 3A&B ). Under these conditions L. lactis NZ9000Glc⎯Lac + used more lactose from the medium (the concentration was lowered by 16.7 mM, compared to 8.0 mM by NZ9000Lac + ) before growth ceased by the lowered pH. Unlike L. lactis NZ9000Lac + , which did not produce glucose, NZ9000Glc⎯Lac + excreted equivalent amounts of glucose (17.1 mM) compared to the lactose consumed (Fig. 3 A&B) . When grown in a fermentor with the pH controlled at 6.5 and lactose as the limiting factor, L. lactis NZ9000Glc⎯Lac + grew to about half of the cell density of NZ9000Lac + (Fig. 3 C&D) . L. lactis NZ9000Glc⎯Lac + produced equimolar amounts of glucose (52.7 mM) from lactose (52.3 mM) under these conditions, while NZ9000Lac + metabolized both the galactose and the glucose moiety of lactose (Fig. 3 C&D) .
When grown under limiting carbon conditions, L. lactis NZ9000Glc⎯Lac + reached a lower cell density than NZ9000Lac + because only half of the total carbon supplied (the galactose moiety of lactose) could be metabolized. A slight accumulation of galactose, most probably resulting from dephosphorylation of galactose-6-phosphate, was observed in L. lactis NZ9000Lac + grown as standing culture and during growth under pH controlled conditions (Fig. 3 A&C) .
To examine whether the characteristics of the strains in synthetic laboratory media would prevail during milk fermentation, L. lactis NZ9000Lac + and NZ9000Glc⎯Lac + were grown in skim milk, in which lactose (~150 mM, which is ~5%) is the main carbon source. Lactose, galactose, and glucose concentrations in the culture supernatants were measured at different growth-stages using HPLC (Fig. 3 e&f) . As in synthetic medium, lactose (46 mM) was used to produce glucose (up to a concentration of 38 mM) by L. formed by lactose-6-phosphate hydrolysis for metabolism, while the glucose moiety of lactose-6-phosphate is expelled into the medium. L. lactis NZ9000Lac + accumulates a transient, low level of galactose, which is consumed upon lactose depletion. This transient extracellular accumulation of galactose indicates that the cell has a clear preference for utilization of the glucose moiety of lactose. Most likely, free galactose results from dephosphorylation of galactose 6-phosphate by a phosphatase as the result of an inducer expulsion mechanism. Such a two-step reaction of inducer expulsion caused by glucose has been described before in L. lactis and other Gram-positive bacteria (156, 198, 220) . When lactose is depleted, the extracellular galactose is used via the Leloir pathway (54). In summary, L. lactis NZ9000Glc⎯Lac + is functional in two ways. First, it could be used to produce glucose from lactose, which could serve as a natural sweetener in fermented dairy products. This in situ produced glucose could replace, at least in part, the frequent addition of other sweeteners to dairy products, as the sweetness of glucose is about 60% of that of sucrose (167). The production of glucose in combination with the lower acidification achieved by L. lactis NZ9000Glc⎯Lac + might
give rise to a milder tasting end-product, e.g. when the strain is used as an adjunct starter culture in cheese or buttermilk production. Second, L. lactis NZ9000Glc⎯Lac + uses only the galactose moiety of lactose for growth, which leads to more effective lactose removal from the medium. Therefore, the strain could be used as a nutraceutical to produce milk fermentation products with lower residual lactose concentrations, which would be suitable in a diet for individuals suffering from lactose intolerance.
